 | Halozyme Therapeutics, Inc. | |||
| NMS : HALO || Location: United States | ||||
$38.64+0.83 (+2.2%) |
1.26 M | 37.73 - 38.69 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 7.886 M |
| March 15, 2024 | 8.202 M |
| Feb. 29, 2024 | 8.083 M |
| Feb. 15, 2024 | 7.647 M |
| Jan. 31, 2024 | 7.637 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.84 | 0.82 | -2.56% |
| 09/30/2023 | 0.72 | 0.75 | 3.96% |
| 06/30/2023 | 0.64 | 0.74 | 15.30% |
| 03/31/2023 | 0.49 | 0.47 | -3.39% |
| 12/31/2022 | 0.48 | 0.48 | 1.03% |
HALO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 127.054M | Shares Float | 125.470M |
| Short Float | 7.886M | Market Cap | 4803.91M |
| Institution ownership | 0.00% | Insider ownership | 1.080% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 2.10 | Forward EPS | 4.56 |